Profile
Michael D.
Levy joined Nuvelo, Inc. in November 2004 as Senior Vice President of Research and Development and was an Executive Vice President of Research and Development in February 2007.
He was Vice President of Development and Chief Medical Officer of Tularik, Inc. from January 2001 to August 2004 and Vice President and the Site Head of Development-San Francisco for Amgen, Inc. from August 2004 to November 2004.
Dr. Levy was Senior Vice President of Research and Development and Chief Medical Officer for Glaxo SmithKline, Inc. He received a BA degree, an MA and an MD from Cambridge University and is a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians.
Former positions of Michael D. Levy
| Companies | Position | End |
|---|---|---|
| Nuvelo, Inc. | Chief Tech/Sci/R&D Officer | 17/03/2008 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | - |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Training of Michael D. Levy
| University of Cambridge | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
| Nuvelo, Inc. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Michael D. Levy
